On November 5, 2020 the medicinal product was officially included in the List of Prequalified Medicinal Products by the World Health Organization (WHO)
Prequalification of medicinal products is a procedure performed by the WHO to assess the quality, safety and efficacy of medicinal products.
The inclusion of the medicinal product in the List of Prequalified Medicinal Products opens up opportunities for Farmak to participate in procurements conducted by international procurement organizations for the needs of the planet population.
Dexamethasone phosphate, except for its main area of intended use, was also included in the list of medicinal products used in the treatment of complications caused by COVID-19.
During the prequalification, the Company underwent the process from the product pharmaceutical development and registration dossier formation to inspection of manufacturing sites by WHO experts.
Each city or town has its own traditions. We follow the old and develop the new ones ourselves. It has become a good tradition for Farmak to congratulate Shostka on its Town Day in a sporty way. The anniversary race “Farmak: Run for Your Health” has been held by the Company for the fifth time. […]
The 5th anniversary race organized by Farmak on the occasion of Shostka Town Day will be held with the support of the local authorities in an offline format under the motto “Run a race and take care of your health!” The race will take place on September 3 in Shostka as part of the celebration of […]
TOP 50 successful Ukrainian brands with a stable reputation and a high level of customer confidence have been determined by the Focus expert magazine. Farmak as the Ukrainian pharmaceutical market leader is among the best. The rating includes both brand companies and brand products from different segments: retail, pharmaceuticals, food industry, telecommunic...